Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ionis Pharmaceuticals Inc (IONS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Deerfield ManagementBOND

James E. Flynn

45,700,000 $48,392 1.9%
2.
Jabre Capital PartnersBOND

Philippe Jabre

3,000,000 $3,167 -25% 0.65%
3. 30,365,000 $32,129 +12% 0.5%
4.
GLG PartnersBOND

Noam Gottesman

9,300,000 $9,853 +44% 0.46%
5.
Empyrean Capital PartnersBOND

Michael A. Price And Amos Meron

7,500,000 $7,917 0.35%
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$44.50 2,000 Officer, Director 4,128 2018-04-17 Filing
$44.30 2,000 Officer, Director 4,128 2018-04-17 Filing
$44.50 4,981 Officer, Director 51,733 2018-04-17 Filing
$44.30 4,981 Officer, Director 51,733 2018-04-17 Filing
$46.15 2,000 Director 9,939 2018-03-29 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 17,307,000 $17,094,989 2.71%
2. 23,600,000 $23,343 0.15%
3. 2,000 $1 0%
4. 1,000 $1 0%
News See All